BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20925647)

  • 1. Clinical pharmacokinetics of ibuprofen arginine.
    Cattaneo D; Clementi E
    Curr Clin Pharmacol; 2010 Nov; 5(4):239-45. PubMed ID: 20925647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the pharmacokinetics of ibuprofen arginate versus dexibuprofen in healthy volunteers.
    Sádaba B; Campanero MA; Muñoz-Juarez MJ; Gil-Aldea I; García-Quetglas E; Esteras A; Azanza JR
    Eur J Clin Pharmacol; 2006 Oct; 62(10):849-54. PubMed ID: 16909273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ibuprofen enantiomers in rats after intravenous and oral administration of ibuprofen arginate.
    Wang XL; Han J; Zhang D; Liu HC
    Yao Xue Xue Bao; 2012 Jan; 47(1):88-93. PubMed ID: 22493811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of absorption rate on pharmacokinetics of ibuprofen in relation to chiral inversion in humans.
    Ding G; Liu Y; Sun J; Takeuchi Y; Toda T; Hayakawa T; Fukushima S; Kishimoto S; Lin W; Inotsume N
    J Pharm Pharmacol; 2007 Nov; 59(11):1509-13. PubMed ID: 17976261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers.
    Zheng C; Hao H; Wang G; Sang G; Sun J; Li P; Li J
    Eur J Drug Metab Pharmacokinet; 2008; 33(1):45-51. PubMed ID: 18543584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective pharmacokinetics of ibuprofen and involved mechanisms.
    Hao H; Wang G; Sun J
    Drug Metab Rev; 2005; 37(1):215-34. PubMed ID: 15747501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of microgravity on the pharmacokinetics of Ibuprofen in humans.
    Idkaidek N; Arafat T
    J Clin Pharmacol; 2011 Dec; 51(12):1685-9. PubMed ID: 21228404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.
    Ochoa D; Prieto-Pérez R; Román M; Talegón M; Rivas A; Galicia I; Abad-Santos F; Cabaleiro T
    Pharmacogenomics; 2015; 16(9):939-48. PubMed ID: 26122864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
    Tornio A; Niemi M; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2007 May; 63(5):463-9. PubMed ID: 17333159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans.
    Knights KM; McLean CF; Tonkin AL; Miners JO
    Br J Clin Pharmacol; 1995 Aug; 40(2):153-6. PubMed ID: 8562298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats.
    Walser S; Hruby R; Hesse E; Heinzl H; Mascher H
    Arzneimittelforschung; 1997 Jun; 47(6):750-4. PubMed ID: 9239454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery.
    Jamali F; Kunz-Dober CM
    Br J Clin Pharmacol; 1999 Apr; 47(4):391-6. PubMed ID: 10233203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of ibuprofen. The first 30 years.
    Davies NM
    Clin Pharmacokinet; 1998 Feb; 34(2):101-54. PubMed ID: 9515184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ibuprofen enantiomers in children with cystic fibrosis.
    Dong JQ; Ni L; Scott CS; Retsch-Bogart GZ; Smith PC
    J Clin Pharmacol; 2000 Aug; 40(8):861-8. PubMed ID: 10934670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies.
    Torrado JJ; Blanco M; Farré M; Roset P; García-Arieta A
    Eur J Clin Pharmacol; 2010 Jun; 66(6):599-604. PubMed ID: 20195587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants.
    Gregoire N; Desfrere L; Roze JC; Kibleur Y; Koehne P
    J Clin Pharmacol; 2008 Dec; 48(12):1460-8. PubMed ID: 18796580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus rectal ibuprofen in healthy volunteers.
    Vilenchik R; Berkovitch M; Jossifoff A; Ben-Zvi Z; Kozer E
    J Popul Ther Clin Pharmacol; 2012; 19(2):e179-86. PubMed ID: 23238355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.
    Lötsch J; Muth-Selbach U; Tegeder I; Brune K; Geisslinger G
    Br J Clin Pharmacol; 2001 Oct; 52(4):387-98. PubMed ID: 11678782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.